Molecular landscape and targeted therapy of acute myeloid leukemia
Abstract For decades, genetic aberrations including chromosome and molecular abnormalities are important diagnostic and prognostic factors in acute myeloid leukemia (AML). ATRA and imatinib have been successfully used in AML and chronic myelogenous leukemia, which proved that targeted therapy by ide...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMC
2018-11-01
|
| Sarja: | Biomarker Research |
| Aiheet: | |
| Linkit: | http://link.springer.com/article/10.1186/s40364-018-0146-7 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|